Xinzhi Medical Lands Millions Of Dollars In Series Pre A Financing

According to China Venture, Shanghai Xinzhi Medical just received a few million dollars in Series Pre A financing. This round of financing was led by CD Capital. The funds will be used to expand production pipelines, Xinzhi Medical will continue to develop more valuable interventional implant-free products around the cardiovascular field.

Xinzhi Medical was founded in 2017, it is a cardiovascular interventional research and development company dedicated to promoting technological innovation in cardiovascular interventional therapy. Its designed "coronary drug balloon" has become the first-class interventional non-implantation solution in the field of cardiovascular disease treatment in China.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with a total size of $600 million.